Form 8-K - Current report:
SEC Accession No. 0001615219-16-000109
Filing Date
2016-02-02
Accepted
2016-02-02 08:16:25
Documents
3
Period of Report
2016-02-02
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a201602028kforpressrelease.htm 8-K 25594
2 EXHIBIT 99.1 a20160202pressrelease.htm EX-99.1 16117
3 companylogoa01.gif GRAPHIC 2462
  Complete submission text file 0001615219-16-000109.txt   46320
Mailing Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199
Business Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199 617-874-1821
Flex Pharma, Inc. (Filer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36812 | Film No.: 161379271
SIC: 2834 Pharmaceutical Preparations